KRYS

Krystal Biotech, Inc. NMS · KRYS

$328.26 -10.96 (-3.23%)

Pullback · -1.30σ

+ Compare Open in Sniper

Valuation

Market cap $9.7B

P/E (ttm) 44.0

Forward P/E 33.3

Beta (5y) 0.50

Shares out 29.5M

Div yield —

Profitability & returns

ROE 19.9%

Net margin 53.9%

FCF margin 33.0%

Debt / equity 0.01

Trading information

Last price $328.26

Day range $326.01 – $337.56

52-wk range $242.00 – $382.54

Avg volume 0.3M

RSI (2) 16.1

Trend zone Pullback

52-week range · today's price

$242.00$382.54

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-03

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bu…